-
UChicago cancer center appoints chief clinical officer
UChicago Medicine Comprehensive Cancer Center has appointed Mitchell Posner, MD, as chief clinical officer. He will also serve as CCO for the health system's cancer service line. -
'Step in the right direction': Cancer experts support alcohol warning labels
Oncologists are praising the surgeon general's decision to add cancer-risk warning labels to alcohol. -
Stanford AI tool outperforms standard cancer prediction models: 5 things to know
Stanford (Calif.) Medicine researchers have trained an AI model to analyze medical imaging data alongside pathology reports to accurately predict cancer prognoses and outcomes, according to a study published Jan. 8 in Nature. -
Childhood cancer deaths fall sixfold over past 70 years
The rate of cancer death in children has dropped sixfold since 1950, Our World in Data reported Jan. 8. -
Philadelphia clinic rewrites the cancer care playbook
When physician Claire Raab, MD, sat down to read the latest cancer catchment data from Fox Chase Cancer Center in Philadelphia, she was floored. -
UI Health Care acquires $280M oncology practice
Iowa City-based University of Iowa Health Care has acquired Mission Cancer + Blood, a physician-owned oncology practice with more than 20 cancer clinics across the state. -
Johns Hopkins, Howard U to 'reignite' health equity alliance
Baltimore-based Johns Hopkins Sidney Kimmel Comprehensive Cancer Center and Washington, D.C.-based Howard University Cancer Center are "reigniting" their established partnership to eliminate health disparities in the Washington, D.C., area. -
Mount Sinai, MSK researchers create AI tool to predict immunotherapy outcomes
Determining which cancer patients are a good candidate for immune checkpoint inhibitors can be a challenge, but researchers at Mount Sinai and Memorial Sloan Kettering Cancer Center have developed a promising tool to predict which patients will respond well to the therapy. -
Fred Hutch spearheads patient confidentiality-focused AI project: What to know
Fred Hutchinson and three other cancer centers are creating a comprehensive AI model without compromising patient confidentiality. -
Topical drug clears precancerous lesions: 5 study notes
A topical immunotherapy drug can effectively eliminate precancerous spots, preventing squamous cell carcinoma occurrence, according to a study published Jan. 2 in the Journal of Clinical Investigation. -
Dana-Farber launches gene therapeutics center
Boston-based Dana-Farber Cancer Institute has launched the Center for RAS Therapeutics, aiming to study and develop drug therapies for RAS-driven cancers. -
New resource for clinical tumor diagnosis
The Grand Rapids, Mich.-based Van Andel Institute has developed a new free and publicly available resource for identifying and classifying cancer subtypes. -
How COVID-19 disrupted cancer care: 4 notes
Cancer screening declined 39% globally during the COVID-19 pandemic, according to a study published Jan. 2 in Nature. -
Cleveland Clinic plans new cancer center in $200M project
Cleveland Clinic submitted plans to the city for approval of a $200 million Fairview Hospital expansion project, including the addition of a new, nearly 170,000-square-foot cancer center, according to a Dec. 12 News 5 Cleveland report. -
Allegheny Health transfers radiation services
Pittsburgh-based Allegheny Health Network has transitioned radiation therapy services out of the Greensburg, Pa.-based AHN Cancer Institute—Hempfield. -
How Jimmy Carter changed cancer care
What remains after the passing of former President Jimmy Carter encompasses more than politics and humanitarianism, it also includes cancer care, according to a Dec. 29 NBC News report. -
How insurance denials disrupt cancer care: 5 investigation notes
As public scrutiny of the health insurance industry continues to mount, another group has emerged among those who claim they have been harmed by insurance company practices. -
Physicians applaud new HPV testing guidance, support self-collection
On Dec. 10, the U.S. Preventive Services Task Force published updated cervical cancer screening recommendations, including guidance that would allow for patients to use self-collection, as opposed to a pelvic exam, for human papillomavirus testing at their physician's office. -
$800M in cancer center gifts from 2024
Though funding models vary throughout the healthcare industry, one revenue source remains constant: the charitable gift. -
Fred Hutch Cancer Center leader to retire
Seattle-based Fred Hutch Cancer Center leader, John Thompson, MD, is retiring at year's end after serving at the organization for 40 years.
Page 1 of 50